Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simulations PlusSLP -0.03%86 Earnings per Share (Diluted) is $0.40 as of May. 2026. GuruFocus rates SLP with a GF Score™ of 86/100 and a GF Value™ of $35.59 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Simulations Plus ranks worse than 83.5% on this metric.
Simulations Plus's EPS (Basic) for the
three
months ended in May. 2026 was $0.18.
Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2026 was $0.40.
During the past 12 months, Simulations Plus's average EPS without NRIGrowth Rate was -34.90% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -18.60% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -4.90% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 6.20% per year.
During the past 13 years, Simulations Plus's highest 3-Year average EPS without NRI Growth Rate was 78.70% per year. The lowest was -39.10% per year. And the median was 15.70% per year.
Simulations Plus (NAS:SLP) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Simulations Plus Earnings per Share (Diluted) Related Terms
Simulations Plus Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Simulations Plus's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simulations Plus Earnings per Share (Diluted) Chart
SLP vs CTEV, TBRG, CARL: Earnings per Share (Diluted) Comparison
For the Health Information Services subindustry, Simulations Plus's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simulations Plus PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's PE Ratio distribution charts can be found below:
* The bar in red indicates where Simulations Plus's PE Ratio falls into.
Simulations Plus Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Simulations Plus's Earnings Per Share (Diluted) for the fiscal year that ended in Aug. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.40 mean?
Simulations Plus (SLP) has a Earnings per Share (Diluted) of $0.40 as of May. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Simulations Plus and its competitors. According to the industry distribution chart, Simulations Plus ranks #425 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 83.5%.
Is Simulations Plus' Earnings per Share (Diluted) too high?
Simulations Plus' current Earnings per Share (Diluted) is $0.40. The Healthcare Providers & Services industry median Earnings per Share (Diluted) is 11.50. Simulations Plus' value of $0.40 is 96.5% below this industry median. Based on the distribution chart, Simulations Plus ranks #425 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Simulations Plus has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Earnings per Share (Diluted) compare to CTEV and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #425 out of 509 companies for Earnings per Share (Diluted). This places Simulations Plus in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.50. Simulations Plus' value of $0.40 is 96.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.50, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current Earnings per Share (Diluted) of $0.40 is 96.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current Earnings per Share (Diluted) is $0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $35.59, compared to a current price of $18.33 — trading 48.5% below its estimated fair value. The current Earnings per Share (Diluted) is $0.40 and 96.5% below the Healthcare Providers & Services industry median of 11.50. Simulations Plus' overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Simulations Plus (SLP), the current Earnings per Share (Diluted) is $0.40 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (SLP) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of $18.33 is trading 48.5% below its estimated GF Value™ of $35.59.
GuruFocus considers Simulations Plus to be Significantly Undervalued.
Key valuation signals for SLP:
Earnings per Share (Diluted): $0.40
GF Value™: $35.59 vs. price of $18.33 (48.5% below fair value)
Industry Position: 96.5% below the Healthcare Providers & Services median (#425 of 509)
No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
86GF Score
Get the complete analysis for SLP
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SLP has been successfully added to your 
